ARTICLE | Clinical News
Pivanex: Phase IIb completed enrollment
May 31, 2004 7:00 AM UTC
TTP completed enrollment of 225 patients in a Phase IIb trial comparing Pivanex plus Taxotere docetaxel from Aventis S.A. (AVE, Strasbourg, France) to docetaxel alone. ...